Personalized Chemotherapy Selection LDT
Solid Tumors (Pancreatic, Colorectal focus)
Pilot Clinical StudiesActive
Key Facts
Indication
Solid Tumors (Pancreatic, Colorectal focus)
Phase
Pilot Clinical Studies
Status
Active
Company
About Encapsulate
Encapsulate is a private, pre-revenue diagnostics company founded in 2021 and headquartered in San Diego, CA, USA. It has developed an automated 'tumor-on-a-chip' platform that creates microtumors from patient biopsies to functionally test drug responses, aiming to personalize cancer therapy selection. The company has secured significant non-dilutive grant funding from NASA and the NSF, closed an oversubscribed $1.8M seed round, and is actively engaged in research, including unique microgravity studies on the International Space Station. Its primary business model is providing diagnostic testing services to oncologists and collaborative R&D services to pharma.
View full company profile